Irritable Bowel Syndrome Treatment Market-Global Forecast to 2023 - PowerPoint PPT Presentation

About This Presentation
Title:

Irritable Bowel Syndrome Treatment Market-Global Forecast to 2023

Description:

Market Research Future one of the well-known brands in market research industry has published a comprehensive analysis of “Irritable Bowel Syndrome Treatment Market-Global Forecast to 2023”. Research prospects in-depth analysis of market size, share, competitive landscape with regional data. – PowerPoint PPT presentation

Number of Views:55

less

Transcript and Presenter's Notes

Title: Irritable Bowel Syndrome Treatment Market-Global Forecast to 2023


1
Irritable Bowel Syndrome Treatment Market
Industry Insights, Growth, Segmentationand
Forecasts to 2023
REQUEST SAMPLE
VIEW REPORTS
2
IRRITABLE BOWEL SYNDROME TREATMENT MARKET
Irritable Bowel Syndrome Treatment Market Global
Forecast to 2023
  • According to Market Research Future (MRFR)s new
    study, the global irritable bowel syndrome
    treatment market is projected to thrive at a CAGR
    of 7.58 during the forecast period 2018 to 2023.
    The valuation of the global market has been
    estimated to reach USD 2,988.6 Mn towards the end
    of 2023 from USD 1,890.9 Mn in 2017.
  • The global market for absorbable surgical sutures
    is expected to grow with a steady rise and is
    expected to continue doing so over the next few
    years.
  • Factors such as increasing lifestyle changes,
    increasing frequency of obesity cases, and
    increasing elderly population in North America
    help to boost the market growth.

3
IRRITABLE BOWEL SYNDROME TREATMENT MARKET
Major Key Players
  • Abbott
  • Allergan Inc
  • Ardelyx Inc
  • Astellas Pharma
  • Ironwood Pharmaceuticals
  • Lexicon Pharmaceuticals
  • Mallinckrodt
  • Nestle Health Science

4
IRRITABLE BOWEL SYNDROME TREATMENT MARKET
Segmentation
  • This MRFR report offers a detailed segmental
    analysis of the global irritable bowel syndrome
    treatment market based on type, drug type, and
    end-user.
  • By type, the market has been segmented into
    IBS-C, IBS-D, and IBS-M. Among these, IBS-D
    segment is currently dominating the global market
    and is projected to retain its dominance in the
    upcoming years.
  • By drug type, the irritable bowel syndrome
    treatment market has been segmented into
    lubiprostone, linaclotide, eluxadoline,
    rifaximin, alosetron, and others.
  • By end-user, the market is segmented into
    hospitals, clinics, research laboratories, and
    others.

Browse Full Report Details and Full TOC
Exclusively _at_ https//www.marketresearchfuture.com
/reports/irritable-bowel-syndrome-treatment-market
-7044
5
ABOUT US
MARKET RESEARCH FUTURE At Market Research Future
(MRFR), we enable our customers to unravel the
complexity of various industries through our
Cooked Research Report (CRR), Half-Cooked
Research Reports (HCRR), Raw Research Reports
(3R), Continuous-Feed Research (CFR), and Market
Research Consulting Services. MRFR team have
supreme objective to provide the optimum quality
market research and intelligence services to our
clients. Our market research studies by products,
services, technologies, applications, end users,
and market players for global, regional, and
country level market segments, enable our clients
to see more, know more, and do more, which help
to answer all their most important questions. In
order to stay updated with technology and work
process of the industry, MRFR often plans
conducts meet with the industry experts and
industrial visits for its research analyst
members. For more information kindly visit
www.marketresearchfuture.com or contact us at
info_at_marketresearchfuture.com Copyright 2018
Market Research Future All Rights Reserved. This
document contains highly confidential information
and is the sole property of Market Research
Future. No part of it may be circulated, copied,
quoted, or otherwise reproduced without the
written approval of Market Research Future.
6
(No Transcript)
Write a Comment
User Comments (0)
About PowerShow.com